Clinical Trial Update: "The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors" [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Exparel against a multidrug cocktail for soft tissue tumors was terminated; the update does not report efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Tumor

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Atlantic Health System | Conditions: Musculoskeletal Diseases, Soft Tissue Mass | Phase 2 | Status: TERMINATED